The group’s principle activity is to provide biopharmaceutical products. The product of the group includes TRX4 and TRX1. The group operates from United States.
Executive Information
Name
Title
Email
Douglas Ringler
Dir., Co - Founder, CEO, Pres.
N/A
Louis Vaickus
Chief Medical Officer
N/A
Thomas Shea
CFO
N/A
Herman Waldmann
Dir., Co - Founder, Chmn., Member - Scientific Advisory Board
